目的 通过分析不同分级慢性阻塞性肺疾病(COPD)稳定期患者胸部定量CT的变化及其与肺功能和症状评分的相关性,探讨其能否做为评估COPD严重程度的方法之一.方法 研究对象为山西医科大学附属大医院呼吸科门诊的90例COPD患者,均行肺功能及胸部定量CT检查,症状评估采用MMRC问卷.根据2011年版GOLD综合评估的方法分为A、B、C和D四组.分别对各组肺功能、胸部定量CT肺气肿评估指标LAA%及症状评分进行相关性分析.结果 ①肺功能:FEV1%pred、VC、DL Adj、FEF75分别在A、B、C和D四组间差异有统计学意义(F分别为59.83,18.56,14.39,16.06,P值均<0.05);且C、D组均分别小于A和B组,差异均有统计学意义(P值均<0.05);A、B组间及C、D组间差异均无统计学意义(P值均>0.05).RV,RV/TLC在A、B、C和D四组间差异无统计学意义(P值均>0.05).②胸部定量CT:LAA%在CT阈值分别-1 024~-970、-960、-950、-940、-930、-920、-910 HU值下均为一致结果.在-i 024~-910 HU下,A、B、C和D四组间LAA%差异有统计学意义(F=20.22,P<0.05),两两比较,C和D组LAA%分别大于A和B组,差异均有统计学意义(P值均<0.05),B组大于A组,差异均有统计学意义(P<0.05),C组与D组差异无统计学意义(P>0.05).③相关性:(a)LAA%与肺功能各指标:在-1 024~-910 HU下LAA%与FEV1% pred、FEF75、DL Adj均呈显著负相关,(r分别为-0.686,-0.509,-0.481,均P<0.01);与RV和RV/TLC无相关性(P=0.34).(b)LAA%与症状评分:在-1 024~-910 HU下LAA%与MMRC呈显著正相关,(r=0.570,P<0.01).(c)症状评分与肺功能各项指标:MMRC与FEV1% pred、FEF75及DL Adj呈显著负相关(r分别为-0.493,-0.330,-0.267,前两者P值均<0.01,后者P<0.05).结论 肺气肿可能为A、B两组患者临床症状出现差异的原因之一.COPD患者气流受限严重程度、小气道功能和弥散功能的改变及症状评分与胸部定量CT肺气肿严重程度相关.对于GOLD肺功能分级轻中度以下(FEV1%pred≥50%)的COPD患者,胸部定量CT LAA%评估肺气肿严重程度优于肺功能.胸部定量CT可以做为评估COPD严重程度的方法之一.
目的 通過分析不同分級慢性阻塞性肺疾病(COPD)穩定期患者胸部定量CT的變化及其與肺功能和癥狀評分的相關性,探討其能否做為評估COPD嚴重程度的方法之一.方法 研究對象為山西醫科大學附屬大醫院呼吸科門診的90例COPD患者,均行肺功能及胸部定量CT檢查,癥狀評估採用MMRC問捲.根據2011年版GOLD綜閤評估的方法分為A、B、C和D四組.分彆對各組肺功能、胸部定量CT肺氣腫評估指標LAA%及癥狀評分進行相關性分析.結果 ①肺功能:FEV1%pred、VC、DL Adj、FEF75分彆在A、B、C和D四組間差異有統計學意義(F分彆為59.83,18.56,14.39,16.06,P值均<0.05);且C、D組均分彆小于A和B組,差異均有統計學意義(P值均<0.05);A、B組間及C、D組間差異均無統計學意義(P值均>0.05).RV,RV/TLC在A、B、C和D四組間差異無統計學意義(P值均>0.05).②胸部定量CT:LAA%在CT閾值分彆-1 024~-970、-960、-950、-940、-930、-920、-910 HU值下均為一緻結果.在-i 024~-910 HU下,A、B、C和D四組間LAA%差異有統計學意義(F=20.22,P<0.05),兩兩比較,C和D組LAA%分彆大于A和B組,差異均有統計學意義(P值均<0.05),B組大于A組,差異均有統計學意義(P<0.05),C組與D組差異無統計學意義(P>0.05).③相關性:(a)LAA%與肺功能各指標:在-1 024~-910 HU下LAA%與FEV1% pred、FEF75、DL Adj均呈顯著負相關,(r分彆為-0.686,-0.509,-0.481,均P<0.01);與RV和RV/TLC無相關性(P=0.34).(b)LAA%與癥狀評分:在-1 024~-910 HU下LAA%與MMRC呈顯著正相關,(r=0.570,P<0.01).(c)癥狀評分與肺功能各項指標:MMRC與FEV1% pred、FEF75及DL Adj呈顯著負相關(r分彆為-0.493,-0.330,-0.267,前兩者P值均<0.01,後者P<0.05).結論 肺氣腫可能為A、B兩組患者臨床癥狀齣現差異的原因之一.COPD患者氣流受限嚴重程度、小氣道功能和瀰散功能的改變及癥狀評分與胸部定量CT肺氣腫嚴重程度相關.對于GOLD肺功能分級輕中度以下(FEV1%pred≥50%)的COPD患者,胸部定量CT LAA%評估肺氣腫嚴重程度優于肺功能.胸部定量CT可以做為評估COPD嚴重程度的方法之一.
목적 통과분석불동분급만성조새성폐질병(COPD)은정기환자흉부정량CT적변화급기여폐공능화증상평분적상관성,탐토기능부주위평고COPD엄중정도적방법지일.방법 연구대상위산서의과대학부속대의원호흡과문진적90례COPD환자,균행폐공능급흉부정량CT검사,증상평고채용MMRC문권.근거2011년판GOLD종합평고적방법분위A、B、C화D사조.분별대각조폐공능、흉부정량CT폐기종평고지표LAA%급증상평분진행상관성분석.결과 ①폐공능:FEV1%pred、VC、DL Adj、FEF75분별재A、B、C화D사조간차이유통계학의의(F분별위59.83,18.56,14.39,16.06,P치균<0.05);차C、D조균분별소우A화B조,차이균유통계학의의(P치균<0.05);A、B조간급C、D조간차이균무통계학의의(P치균>0.05).RV,RV/TLC재A、B、C화D사조간차이무통계학의의(P치균>0.05).②흉부정량CT:LAA%재CT역치분별-1 024~-970、-960、-950、-940、-930、-920、-910 HU치하균위일치결과.재-i 024~-910 HU하,A、B、C화D사조간LAA%차이유통계학의의(F=20.22,P<0.05),량량비교,C화D조LAA%분별대우A화B조,차이균유통계학의의(P치균<0.05),B조대우A조,차이균유통계학의의(P<0.05),C조여D조차이무통계학의의(P>0.05).③상관성:(a)LAA%여폐공능각지표:재-1 024~-910 HU하LAA%여FEV1% pred、FEF75、DL Adj균정현저부상관,(r분별위-0.686,-0.509,-0.481,균P<0.01);여RV화RV/TLC무상관성(P=0.34).(b)LAA%여증상평분:재-1 024~-910 HU하LAA%여MMRC정현저정상관,(r=0.570,P<0.01).(c)증상평분여폐공능각항지표:MMRC여FEV1% pred、FEF75급DL Adj정현저부상관(r분별위-0.493,-0.330,-0.267,전량자P치균<0.01,후자P<0.05).결론 폐기종가능위A、B량조환자림상증상출현차이적원인지일.COPD환자기류수한엄중정도、소기도공능화미산공능적개변급증상평분여흉부정량CT폐기종엄중정도상관.대우GOLD폐공능분급경중도이하(FEV1%pred≥50%)적COPD환자,흉부정량CT LAA%평고폐기종엄중정도우우폐공능.흉부정량CT가이주위평고COPD엄중정도적방법지일.
Objective Through the analysis of the patients's Chest quantitative CT changes that with different classification of chronic obstructive pulmonary disease (COPD) and pulmonary function and the correlation of symptom scores,and discussed it can be or not as a way of assessment of the severity of COPD.Methods The research object were our respiratory medicine outpatient service of 90 cases of patients with COPD,each patient did pulmonary function and chest quantitative CT examination,the symptom assessment using MMRC questionnaire.According to the 2011 GOLD guide joint assessment method is divided into A,B,C and D groups.Each group respectively on pulmonary function,chest CT pulmonary emphysema quantitative evaluation index LAA % and symptom scores for correlation analysis.Results ① Pulmonary function.-The four FEV1 % pred,VC,DL Adj,FEF75 were statistically significant difference respectively in A,B,C and D four groups.(F =59.83,18.56,14.39,16.06,allP <0.05),and C,D group respectively are less than A and B group,the differences were statistically significant (P <0.05),A and B,C and D between-group differences were no statistical significance (P >0.05).RV,RV/TLC in A,B,C and D four groups difference was not statistically significant (P >0.05).②Chest quantitative CT:LAA% In CT threshold respectively-1 024 ~-970,~-960,~-950,~-940,~-930,~-920,~-910 HU values are consistent results,in-1 024~-9 10 HU,LAA % in A,B,C and D four groups's difference have statistical significance (F =20.22,P <0.05),pairwise comparation,LAA% in C and D group were greater than A and B group,the differences were statistically significant (P < 0.05).Group B more than in group A,the differences were statistically significant (P < 0.05).C and D group difference was not statistically significant (P >0.05).③ Correlation..(a)LAA% and pulmonary function each index LAA% (in-1 024~-910 HU),with FEV:% pred,FEF75,DL Adj all has significant negative correlation,(r =-0.686,-0.509,-0.481,all P <0.01),And with RV and RV/TLC have no correlation (P =0.34).(b)LAA % and symptom scores LAA% (in-1 024~-910 HU) and MMRC is a significant positive correlation,(r =0.570,P <0.01).(c)Symptom scores and pulmonary function each index MMRC and FEV1 %pred,FEF75 and DL Adj has significant negative correlation (r =0.493,0.330,0.267,and the two before P <0.01,the latter P <0.05).Conclusions Emphysema may be a reason for the differences of A,B two groups of patients with clinical symptoms.Patients with COPD airflow restricted severity,small airway function and dispersion function changes and the symptom score are which with chest quantitative CT pulmonary emphysema severity are correlation.GOLD for lung function classification under mildmoderate patients with COPD (FEV1% pred ≥ 50%),chest quantitative CT LAA% evaluation emphysema is better than that of severity of pulmonary function.Chest quantitative CT ia one way of a assessment of the severity of COPD.